Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways

Peter J. Naus, Roger Henson, Grant Bleeker, Hania Wehbe, Fanyin Meng, Tushar C Patel

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Background/Aims: Tannic acid is an orally active plant polyphenol with potential for use as an anti-cancer agent for cholangiocarcinoma. To determine the potential use of tannic acid as an adjunct therapy, we sought to evaluate the interaction between tannic acid and chemotherapeutic agents. Methods: Cytotoxicity was assessed in malignant human cholangiocytes. Interactions between tannic acid, mitomycin C, 5-fluorouracil and gemcitabine were quantitated by calculating the combination index and dose reduction index. Cellular efflux pathways were assessed by calcein retention assays, and expression of membrane pumps was assessed by Western blots and real-time PCR. Results: Tannic acid and the three agents decreased growth of malignant cholangiocytes to a similar extent. Tannic acid had a synergistic effect to mitomycin C and 5-fluorouracil, but not gemcitabine. However, the structurally related polyphenol gallic acid did not have a synergistic interaction with any of the agents. Tannic acid decreased calcein efflux and the expression of PGP, MRP1 and MRP2 membrane efflux pumps. Conclusions: Tannic acid has a synergistic effect with selected chemotherapeutic drugs by a mechanism involving modulation of drug efflux pathways. Thus, tannic acid will be a useful adjunct to improve the effectiveness of chemotherapeutic agents in the treatment of cholangiocarcinoma.

Original languageEnglish (US)
Pages (from-to)222-229
Number of pages8
JournalJournal of Hepatology
Volume46
Issue number2
DOIs
StatePublished - Feb 2007
Externally publishedYes

Fingerprint

Cholangiocarcinoma
Tannins
Pharmaceutical Preparations
gemcitabine
Polyphenols
Mitomycin
Fluorouracil
Gallic Acid
Membranes
Real-Time Polymerase Chain Reaction
Western Blotting

Keywords

  • Biliary cancers
  • Chemotherapy
  • Pharmacology
  • Plant polyphenol
  • Treatment

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways. / Naus, Peter J.; Henson, Roger; Bleeker, Grant; Wehbe, Hania; Meng, Fanyin; Patel, Tushar C.

In: Journal of Hepatology, Vol. 46, No. 2, 02.2007, p. 222-229.

Research output: Contribution to journalArticle

Naus, Peter J. ; Henson, Roger ; Bleeker, Grant ; Wehbe, Hania ; Meng, Fanyin ; Patel, Tushar C. / Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways. In: Journal of Hepatology. 2007 ; Vol. 46, No. 2. pp. 222-229.
@article{1701a1f833e44d91a477cb9024d78cb8,
title = "Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways",
abstract = "Background/Aims: Tannic acid is an orally active plant polyphenol with potential for use as an anti-cancer agent for cholangiocarcinoma. To determine the potential use of tannic acid as an adjunct therapy, we sought to evaluate the interaction between tannic acid and chemotherapeutic agents. Methods: Cytotoxicity was assessed in malignant human cholangiocytes. Interactions between tannic acid, mitomycin C, 5-fluorouracil and gemcitabine were quantitated by calculating the combination index and dose reduction index. Cellular efflux pathways were assessed by calcein retention assays, and expression of membrane pumps was assessed by Western blots and real-time PCR. Results: Tannic acid and the three agents decreased growth of malignant cholangiocytes to a similar extent. Tannic acid had a synergistic effect to mitomycin C and 5-fluorouracil, but not gemcitabine. However, the structurally related polyphenol gallic acid did not have a synergistic interaction with any of the agents. Tannic acid decreased calcein efflux and the expression of PGP, MRP1 and MRP2 membrane efflux pumps. Conclusions: Tannic acid has a synergistic effect with selected chemotherapeutic drugs by a mechanism involving modulation of drug efflux pathways. Thus, tannic acid will be a useful adjunct to improve the effectiveness of chemotherapeutic agents in the treatment of cholangiocarcinoma.",
keywords = "Biliary cancers, Chemotherapy, Pharmacology, Plant polyphenol, Treatment",
author = "Naus, {Peter J.} and Roger Henson and Grant Bleeker and Hania Wehbe and Fanyin Meng and Patel, {Tushar C}",
year = "2007",
month = "2",
doi = "10.1016/j.jhep.2006.08.012",
language = "English (US)",
volume = "46",
pages = "222--229",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways

AU - Naus, Peter J.

AU - Henson, Roger

AU - Bleeker, Grant

AU - Wehbe, Hania

AU - Meng, Fanyin

AU - Patel, Tushar C

PY - 2007/2

Y1 - 2007/2

N2 - Background/Aims: Tannic acid is an orally active plant polyphenol with potential for use as an anti-cancer agent for cholangiocarcinoma. To determine the potential use of tannic acid as an adjunct therapy, we sought to evaluate the interaction between tannic acid and chemotherapeutic agents. Methods: Cytotoxicity was assessed in malignant human cholangiocytes. Interactions between tannic acid, mitomycin C, 5-fluorouracil and gemcitabine were quantitated by calculating the combination index and dose reduction index. Cellular efflux pathways were assessed by calcein retention assays, and expression of membrane pumps was assessed by Western blots and real-time PCR. Results: Tannic acid and the three agents decreased growth of malignant cholangiocytes to a similar extent. Tannic acid had a synergistic effect to mitomycin C and 5-fluorouracil, but not gemcitabine. However, the structurally related polyphenol gallic acid did not have a synergistic interaction with any of the agents. Tannic acid decreased calcein efflux and the expression of PGP, MRP1 and MRP2 membrane efflux pumps. Conclusions: Tannic acid has a synergistic effect with selected chemotherapeutic drugs by a mechanism involving modulation of drug efflux pathways. Thus, tannic acid will be a useful adjunct to improve the effectiveness of chemotherapeutic agents in the treatment of cholangiocarcinoma.

AB - Background/Aims: Tannic acid is an orally active plant polyphenol with potential for use as an anti-cancer agent for cholangiocarcinoma. To determine the potential use of tannic acid as an adjunct therapy, we sought to evaluate the interaction between tannic acid and chemotherapeutic agents. Methods: Cytotoxicity was assessed in malignant human cholangiocytes. Interactions between tannic acid, mitomycin C, 5-fluorouracil and gemcitabine were quantitated by calculating the combination index and dose reduction index. Cellular efflux pathways were assessed by calcein retention assays, and expression of membrane pumps was assessed by Western blots and real-time PCR. Results: Tannic acid and the three agents decreased growth of malignant cholangiocytes to a similar extent. Tannic acid had a synergistic effect to mitomycin C and 5-fluorouracil, but not gemcitabine. However, the structurally related polyphenol gallic acid did not have a synergistic interaction with any of the agents. Tannic acid decreased calcein efflux and the expression of PGP, MRP1 and MRP2 membrane efflux pumps. Conclusions: Tannic acid has a synergistic effect with selected chemotherapeutic drugs by a mechanism involving modulation of drug efflux pathways. Thus, tannic acid will be a useful adjunct to improve the effectiveness of chemotherapeutic agents in the treatment of cholangiocarcinoma.

KW - Biliary cancers

KW - Chemotherapy

KW - Pharmacology

KW - Plant polyphenol

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=33845659501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845659501&partnerID=8YFLogxK

U2 - 10.1016/j.jhep.2006.08.012

DO - 10.1016/j.jhep.2006.08.012

M3 - Article

C2 - 17069924

AN - SCOPUS:33845659501

VL - 46

SP - 222

EP - 229

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 2

ER -